Canada Pension Plan Investment Board’s Stemline Therapeutics, Inc. STML Stock Holding History

Canada Pension Plan Investment Board’s Portfolio STML Stock Details STML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-700	Closed	-$14K	–	1328
2014 Q1	$14K	Buy	+700	New	+$17K	﹤0.01%	1261

Other funds holding STML

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCA

Private Capital Advisors Darien, Connecticut $872M AUM 26.12% 1-Year Est. Return

Canada Pension Plan Investment Board's STML Position: Q2 2014 in Review

Canada Pension Plan Investment Board sold out of Stemline Therapeutics, Inc. (STML) in Q2 2014, closing a stake of 700 shares — an estimated $14K sold.

Canada Pension Plan Investment Board first reported a position in STML in Q1 2014 and held it in 1 quarter. The position peaked at $14K in Q1 2014. 61 funds tracked by Wall St. Rank hold STML as of Q2 2014.

Canada Pension Plan Investment Board reported no remaining Stemline Therapeutics, Inc. position as of Q2 2014 after selling out during the quarter.
Canada Pension Plan Investment Board sold 700 Stemline Therapeutics, Inc. shares in Q2 2014, an estimated $14K.
Canada Pension Plan Investment Board first reported a position in Stemline Therapeutics, Inc. in Q1 2014 and held it in 1 quarter.
Canada Pension Plan Investment Board's Stemline Therapeutics, Inc. position peaked at $14K in Q1 2014.
61 funds tracked by Wall St. Rank held Stemline Therapeutics, Inc. as of Q2 2014.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2014, filed 13 Aug 2014.